Skip to main content
main-content

Gout and crystal arthropathies

Comorbidities

15-04-2019 | Biomarkers | News

Calprotectin levels separate septic arthritis from other inflammatory arthritides

Levels of calprotectin in the synovial fluid can be used to discriminate patients with septic arthritis from those with pseudogout and rheumatoid arthritis, shows a report published in Rheumatology.

12-04-2019 | Gout | Editorial | Article

Using genetic studies to assess the impact of hyperuricemia in cardiometabolic and chronic kidney disease

Editorial Board member Fernando Pérez-Ruiz discusses the impact of hyperuricemia in cardiometabolic and chronic kidney disease, focusing on the role of genetic studies in showing a causal association between these conditions.

Using genetic studies to assess the impact of hyperuricemia in cardiometabolic and chronic kidney disease

Editorial Board member Fernando Pérez-Ruiz discusses the impact of hyperuricemia in cardiometabolic and chronic kidney disease, focusing on the role of genetic studies in showing a causal association between these conditions.

Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

31-10-2018 | Psoriatic arthritis | ACR/ARHP 2018 | Article

From the Editorial Board: Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

Hyperuricemia and chondrocalcinosis: A clinical challenge for diagnosis and treatment

Editorial board member Fernando Pérez-Ruiz presents an interesting presentation of coexistant hyperuricemia and chondrocalcinosis, and outlines the challenges of diagnosis and management of these conditions.

18-10-2018 | Crystal arthropathies | Case study | Article

Hyperuricemia and chondrocalcinosis: A clinical challenge for diagnosis and treatment

Editorial board member Fernando Pérez-Ruiz presents an interesting presentation of coexistant hyperuricemia and chondrocalcinosis, and outlines the challenges of diagnosis and management of these conditions.

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

11-10-2018 | Gout | Highlight | News

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

07-09-2018 | Gout | News

Risk for gout in obstructive sleep apnea patients highest after a year

A large cohort study from the UK has confirmed that the risk for gout is increased in people with obstructive sleep apnea, and shows that the risk peaks 1–2 years after diagnosis.

30-08-2018 | Gout | Article

The risk of gout among patients with sleep apnea: A matched cohort study

Blagojevic-Bucknall M et al. Arthritis Rheumatol 2018. doi: 10.1002/art.40662

20-08-2018 | Gout | Article

Gout and hearing impairment in the elderly: A retrospective cohort study using the US Medicare claims data

Singh JA, Cleveland JD. BMJ Open 2018; 8: e022854. doi: 10.1136/bmjopen-2018-022854

26-07-2018 | Gout | News

Gout may increase atrial fibrillation risk in older people

Having gout is associated with an increased risk for atrial fibrillation among people aged 65 years and older, study results suggest.

19-07-2018 | Gout | News

Modifiable risk factors for gout confirmed in meta-analysis

Obesity, hypertension, and diuretic use are all independently associated with a doubling in the risk for gout, results of a systematic review and meta-analysis suggest.

15-07-2018 | Gout | Article

Gout and the risk of incident erectile dysfunction: A body mass index-matched population-based study

Schlesinger N, Lu N, Choi K. J Rheumatol 2018. doi: 10.3899/jrheum.170444

11-07-2018 | Gout | Article

Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study

Pisaniello HL et al. Arthritis Res Ther 2018; 20: 143. doi: 10.1186/s13075-018-1633-9

05-07-2018 | Gout | Article

Obesity, hypertension and diuretic use as risk factors for incident gout: A systematic review and meta-analysis of cohort studies

The aim of this systematic review and meta-analysis was to assess the risk of incident gout associated with obesity, hypertension and diuretic use.

Evans PL et al. Arthritis Res Ther 2018; 20: 136. doi: 10.1186/s13075-018-1612-1

05-07-2018 | Gout | Article

Mediation analysis to understand genetic relationships between habitual coffee intake and gout

Hutton J et al. Arthritis Res Ther 2018; 20: 135. doi: 10.1186/s13075-018-1629-5

Obesity, hypertension and diuretic use as risk factors for incident gout: A systematic review and meta-analysis of cohort studies

The aim of this systematic review and meta-analysis was to assess the risk of incident gout associated with obesity, hypertension and diuretic use [read more].
Evans PL et al. Arthritis Res Ther 2018; 20: 136. doi: 10.1186/s13075-018-1612-1

21-06-2018 | Pathogenesis | Review | Article

The role of neutrophil extracellular traps in rheumatic diseases

Apel F, Zychlinsky A, Kenny EF. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0039-z

image credits